Current Issue: Q4 2020

The Innovation Issue

The Future of Healthcare

Our fourth quarter edition features leading insights from subject matter experts covering a range of topics, with a focus on innovations driving the future of healthcare, including solutions to the COVID-19 pandemic. In this issue, leaders from all facets of the pharmaceutical industry discuss their approach to developing and distributing COVID-19 vaccines globally, enabling innovation, facilitating decentralized clinical trials, stem cell technology, and ways to communicate and conduct marketing virtually during the pandemic.

Download Issue

Also in This Issue

Cover Story

Facing the Challenges of the COVID-19 Pandemic: Rentschler Biopharma

Rentschler Biopharma highlights their focus on clients' COVID-19 programs, including manufacturing support for the BioNTech/Pfizer mRNA vaccine.

Nice Insight Overview

Delivering Vaccines During a Pandemic

Nigel Walker discusses delivering vaccines during a pandemic.

Single-Use Technology

Stainless Steel to Single-Use: How to Adapt to the Changing Landscape in SUT

Ryan MacDonald, Senior Engineer, Manufacturing Quality Sciences at Avid Bioservices, discusses the company's adoption of single-use technology.

Industry Leader

Shaping the Future of Biopharma Through Next-Generation Contract Drug Manufacturing

In our Q4 cover story, Rentschler Biopharma SE's CEO Frank Mathias, Ph.D., explains how the company develops best-fit solutions for complex client challenges to face the future of biopharmaceuticals.

Clinical Trials

Modern Strategies for Dermatology Clinical Trials

Rose Blackburne M.D., John Manns, Tim Rich, and Michael Noss, M.D. of PPD discuss how decentralized clinical trials strategies enable dermatological clinical trials.

Hot Melt Extrusion

Solving Solubility Challenges with a Polyvinyl Alcohol Excipient and Hot Melt Extrusion

Polyvinyl alcohol excipients can optimize API solubility in hot melt extrusion formulations, explain Daniel J. Price, Ph.D., and Thomas Kipping, Ph.D. of MilliporeSigma.

COVID-19 vaccine

How COVID-19 Is Reshaping Vaccine Development: Innovations in Vaccine Technology and Partnerships

Graham Brearley of Catalent and Jared Davis, formerly of Arcturus Therapeutics, discuss the partnership between the companies to manufacture a COVID-19 mRNA vaccine.

Digital Transformation

Seamlessly Sharing Supply Chain Information to Deliver Measurable Efficiencies for Clients

PCI Pharma Services' Director of Digital Products Morgan Brandt explains how PCI's digital transformation and the launch of pci | bridge provides customers with real-time data access to comprehensive supply chain information.

Personalized Medicines

Disruptive Technologies in Life Sciences: Personalized Medicines

A panel of experts from Corning Life Sciences explain how organoids and other emerging technologies are enabling personalized medicine.

Corporate Social Responsibility

Life Imitating Science: Arranta Bio’s Commitment to Corporate Social Responsibility and Diversity

Melanie Cerullo and Susan Surabian highlight Arranta Bio's commitment to corporate social responsiblity and diversity.

Extractables & Leachables

Aiding Material Qualification and Risk Assessment for Single-Use Biomanufacturing

Jessica Shea explains how MilliporeSigma's Emprove Program helps aid customers in the evaluation of extractables and leachables.

Virtual Trade Shows

Meeting the Challenges of the Pandemic through Virtual Trade Shows

In this Q&A, Justin Kadis of Federal Equipment Company explains how the company responded to the challenges of COVID-19 by pioneering virtual trade shows.

Small Molecule

The Importance of a Global Leader in Small Molecule Manufacturing During the COVID-19 Pandemic

Pierre Luzeau, Chief Executive Officer of Seqens, explains how the company is investing and growing to meet the challenges of the future of small molecule manufacturing.

Digital Marketing

Creating Quality Content for Effective Digital Marketing

Rizwan Chaudhrey, founder and CEO of RSK Life Science Media, explores the importance of social media in digital marketing.

Modular Facilities

Controlling the Cost of Ownership with Modular Facility Construction

Aaron Styles, Vice President of Environmental Systems Corporation explains how modular construction models can increase efficiency and reduce costs of construction.

COVID-19 Vaccine Distribution

Preparing for COVID-19 Vaccine Distribution Despite Tight Shipping Capacity

Andrew T. Boyle, Co-president of Boyle Transportation, explains the challenges ahead in the distribution of a COVID-19 vaccine.

Mobile Research Nursing

Mobile Research Nursing: Evolving to Meet Pandemic Challenges

Mobile research nursing is critical to the success of decentralized clinical trials during the pandemic, explains Jules Moritz, COO of Illingworth Research Group Ltd.

Feature Story

Wearable Technology: Innovation, Adherence, and Clinical Outcomes

The Pharma's Almanac team looks at how wearables may transform clinical trials and beyond.

Feature Story

Wearable Technology: Targeting a Range of Uses and Indications

Our editors explore the range of potential indications and applications for wearable technologies.

Feature Story

Wearable Technology: Their Future in Clinical Trials and the Real World

The Pharma's Almanac team looks at how wearables may transform clinical trials and beyond.

Antibody–Drug Conjugates

Preparing for the ADC Explosion with End-to-End Support

Jyothi Swamy, Ph.D., and Elizabeth McKee describe how MilliporeSigma has established itself as a CDMO supporting all aspects of ADC programs.

Gene Sequencing

Expanding Laboratory Access to Gene Sequencing

New technology is bringing Sanger DNA sequencing to the benchtop, details Gabriela Saldanha of Promega Corporation.

COVID-19 Therapeutics

How an Agile Company Addressed the Pandemic: Moving from Psychiatric Medicines to a COVID-19 Therapeutic

Jonathan Javitt, M.D., discusses how NeuroRx has shifted focus from a psychiatric pipeline to pursue a promising therapeutic for COVID-19.

Natural Killer T cells

Combating Cancer and Other Diseases with Supercharged NKT Cells

Nice Insight's Emilie Branch explores how AVM Biotechnology is approaching immun-onocology with a novel formulation of dexamethasone that mobilizes NKT cells.

Supply Chain

Nationalism and the Pharmaceutical Supply Chain

The COVID-19 pandemic has exposed existing weaknesses in international supply chains, explains Haig Armaghanian, Founder and CEO of Haig Barrett.

Stem Cells

Changing the Paradigm of Stem Cell Technology

Allogeneic, undifferentiated pluripotent stem cells have the potential to transform the treatment of neurodegenerative diseases, explains Sandy Solmon of Celavie Biosciences.

Single-Cell Analytics

Enabling Pharma Researchers to Think Differently with Effective Data Manipulation

Elastic computing has considerable potential to enable single-cell omics and analytics, according to Paradigm4's Marilyn Matz and Zachary Pitluk, Ph.D.

Specialized OSD Services

Avara Pharmaceutical Services: Specialization with a Client-Centric Approach

Deborah A. Graham of Avara Pharmaceutical Services explains how Avara supports clients through specialized OSD services.

AAV Platform Technologies

Increasing Predictability with AAV Platform Technologies

The development of AAV platform technologies will be key to increasing efficiency and unlocking the potential of gene therapies, explains Felix Hsu, CCO of WuXi Advanced Therapies.

Preclinical

Increasing the Efficiency of Drug Development with Preclinical Testing Using Human Intestinal Stem Cells

Increasing the Efficiency of Drug Development with Preclinical Testing Using Human Intestinal Stem Cells, Altis Biosystems, Ron Laethem

Ophthalmic Formulation

Targeting Retinal Diseases with an Ophthalmic Formulation of Bevacizumab

Larry Kenyon explains how Outlook Therapeutics is addressing retinal diseases via the first ophthalmic formulation of bevacizumab.

Diversification

Product Diversification Through Expansion into the Animal Health Market

TriRx Pharmaceutical Services' CEO Tim Tyson discusses the company's expansion into animal health development and manufacturing.

There Were No Passengers On This Journey

The That's Nice road team prepares for their pan-European journey to explore the future of healthcare.

Trip Kickoff at Home House in Kensington, London

Day 0: England

Setting Off On The Road To 2021

Day 1: England and Wales

Exploring The Emerald Isle Without Pubs

Day 2: Wales, Ireland, and Northern Ireland

Scotland, Our Collective Favorite Stop Of The Trip

Day 3: Scotland and England

Southward Through The UK And Across The Channel To Europe

Day 4: France and Belgium

A Gorgeous And Relaxing Day In The Bene Region

Day 5: Belgium and the Netherlands

A Day Of Serious Driving Across Germany And Into Denmark

Day 6: The Netherlands, Germany, and Denmark

Heavy Rain and Nobel Prizes

Day 7: Denmark and Sweden

A Relaxing Voyage Past the Fjords

Day 8: Sweden and Finland

Onward into the Baltics

Day 9: Finland, Estonia and Latvia

Police Encounter and Soviet Aircraft

Day 10: Latvia and Lithuania

Crosses on the Road to Warsaw

Day 11: Lithuania and Poland

A Change of Plans Leads us to Prague

Day 12: Poland and the Czech Republic

Learning About Pharmacovigilance in Bratislava

Day 13: The Czech Republic and Slovakia

Meeting Two Trip Sponsors in Bratislava

Day 14: Slovakia and Hungary

Preclinical Trials and Personalized Dosing

Day 15: Hungary and Croatia

Public Healthcare Trumps Private in Eastern Europe

Day 16: Croatia, Slovenia, and Austria

Recharging At The Alpine Pass

Day 17: Austria

Four Countries In A Day, But Few Masks

Day 18: Austria, Germany, Liechtenstein, and Switzerland

Understanding The Swiss Way

Day 19: Switzerland and Italy

The (Pedestrian) Road Through Milano

Day 20: Italy

Monte Carlo And Along The French Riviera

Day 21: Italy, Monaco, and France

Hitting Our 27th Country In 22 Days

Day 22: France and Luxembourg

The Future Of Personalized Medicine In Luxembourg

Day 23: France and Luxembourg

Paris Sites And Digital Solutions

Day 24: France

It’s The End Of This Journey, But The Start Of The Next One

Day 25: France and England

The Future of Healthcare

How Does SanaClis Envision the Future of the Pharma/Biopharma Industry?

SanaClis assesses the pandemic's impacts on clinical trials models.

The Future of Healthcare

How Does Polpharma Biologics Envision the Future of the Pharma/Biopharma Industry?

Polpharma Biologics sees the acceleration of development timelines as a key outcome of the pandemic.

The Future of Healthcare

How Does Yourway Envision the Future of the Pharma/Biopharma Industry?

Yourway discusses trends changing the clinical trial landscape and how the company is investing to support them.

The Future of Healthcare

How Does Inceptor Bio Envision the Future of the Pharma/Biopharma Industry?

Inceptor Bio highlights disruptive technologies on the horizon and the long-term impacts of COVID-19.

The Future of Healthcare

How Does Pii Envision the Future of the Pharma/Biopharma Industry?

Pii explore how the intersection of scientific innovation and accelerated timelines will drive the future of pharma.

The Future of Healthcare

How Does Federal Equipment Company Envision the Future of the Pharma/Biopharma Industry?

Federal Equipment Company explores how technological innovations are keeping the used equipment market viable in pandemic times.

The Future of Healthcare

How Does Arranta Bio Envision the Future of the Pharma/Biopharma Industry?

Arranta Bio highlights technological innovations needed to realize the potential of microbiome therapies.

The Future of Healthcare

How Does SGD Pharma Envision the Future of the Pharma/Biopharma Industry?

SGD Pharma discusses the impact of the COVID-19 pandemic on the glass pharmaceutical packaging market.

The Future of Healthcare

How Does AES Clean Technologies Envision the Future of the Pharma/Biopharma Industry?

AES Clean Technology explore the future of cleanrooms and contamination-control technologies.

The Future of Healthcare

How Does Avara Pharmaceutical Services Envision the Future of the Pharma/Biopharma Industry?

Avara Pharmaceutical Services discusses how they are investing and building relationships to meet customer needs beyond the pandemic.

The Future of Healthcare

How Does Globyz Biopharma Services Envision the Future of the Pharma/Biopharma Industry?

Globyz Biopharma Services looks forward to supporting clinical trials in a more virtual future.

The Future of Healthcare

How Does SPI Pharma Envision the Future of the Pharma/Biopharma Industry?

SPI Pharma emphasizes the importance of innovations focused on the patient experience going forward.

The Future of Healthcare

How Does Dynamk Capital Envision the Future of the Pharma/Biopharma Industry?

Dynamk Capital is focused on the future as they monitor potentially disruptive innovations.

The Future of Healthcare

How Does TriRx Envision the Future of the Pharma/Biopharma Industry?

TriRx Pharmaceutical Services discusses trends shaping the future of pharma and the critical role for CDMOs.

The Future of Healthcare

How Does Evolve Envision the Future of the Pharma/Biopharma Industry?

Evolve Biologics believes that their PlasmaCap EBA technology will transform the future of the plasma proteins market.

The Future of Healthcare

How Does ECRI Envision the Future of the Pharma/Biopharma Industry?

ECRI explains how an increased emphasis on patient safety will continue to transform the industry.

The Future of Healthcare

How Does Altis Biosystems Envision the Future of the Pharma/Biopharma Industry?

Altis Biosystems discusses the potentially transformative role of in vitro tissue models in preclinical testing.

COVID-19 Impacts

Q: What do you think is the greatest lesson learned from the COVID-19 pandemic, and what lasting impacts do you foresee over the next 5–10 years?

A panel of SMEs discusses the lasting impacts of the COVID-19 pandemic.

Roundtable

Q: Although there is no such thing as a truly “crisis-proof” organization, how are you working to mitigate risks for future crises like the COVID-19 pandemic?

Industry experts explore what it takes to make an organization "crisis-proof."

Issue Q3 2020

The Outsourcing Issue

View Issue »
Issue #3 | Volume #6 | Q3 2020
Issue Q2 2020

The Next-Generation Issue

View Issue »
Issue #2 | Volume #6 | Q2 2020
Issue Q1 2020

The Executive Issue

View Issue »
Issue #1 | Volume #6 | Q1 2020
Issue Q4 2019

The Breakthrough Issue

View Issue »
Issue #4 | Volume #5 | Q4 2019